NHWK
|
NightHawk Biosciences, Inc.
|
US
|
AMEX
|
NOTV
|
Inotiv, Inc.
|
US
|
NASDAQ
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
PNT
|
POINT Biopharma Global Inc.
|
US
|
NASDAQ
|
PTN
|
Palatin Technologies, Inc.
|
US
|
AMEX
|
REUN
|
Reunion Neuroscience Inc.
|
US
|
NASDAQ
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
RPRX
|
Royalty Pharma plc
|
US
|
NASDAQ
|
SPRC
|
SciSparc Ltd.
|
US
|
NASDAQ
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
US
|
NASDAQ
|
VYNT
|
Vyant Bio, Inc.
|
US
|
NASDAQ
|
ACR
|
Acrux Limited
|
AU
|
ASX
|
IVX
|
Invion Ltd
|
AU
|
ASX
|
NOX
|
Noxopharm Ltd
|
AU
|
ASX
|
NYR
|
Nyrada Inc.
|
AU
|
ASX
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
DMPWW
|
Delmar Pharmaceuticals Inc - Warrants [16/08/202
|
US
|
OTC
|
GNNSF
|
Genscript Biotech Corp
|
US
|
OTC
|
HRBR
|
Harbor Biosciences Inc
|
US
|
OTC
|
IVIXF
|
Invion Ltd
|
US
|
OTC
|